S&P 500 7,561.67 −0.40%
Nasdaq 25,136.27 −0.91%
S&P/TSX 36,105.90 −0.09%
Apple 356.27 +0.39%
Nvidia 162.85 −2.01%
Microsoft 523.88 +0.17%
Shopify 209.74 +0.16%
Royal Bank 288.37 −0.35%
CAD/USD 0.7008 −0.06%
CLOSED · 23:35 ET
Market ClerkRecap
Sat Nov 14 · markets closed3 signals today368 insider buys this week · $138.2MCIRO short report next: Nov 15The week ahead
RC
INSIDER · MNPR · Monopar Therapeutics · CHIEF EXECUTIVE OFFICER

Robinson Chandler

Every open-market transaction filed under this name, Sep 24 to Sep 24.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$2.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 24MNPRMonopar TherapeuticsChief Executive OfficerSell600$89.79$54K−20.5%
Sep 24MNPRMonopar TherapeuticsChief Executive OfficerSell8,368$88.97$745K−19.7%
Sep 24MNPRMonopar TherapeuticsChief Executive OfficerSell9,638$87.96$848K−18.8%
Sep 24MNPRMonopar TherapeuticsChief Executive OfficerSell10,450$87.15$911K−18.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.